Submitted by Anonymous (not verified) on 11 April 2025 - 15:45
Human medicines European public assessment report (EPAR): Edurant, rilpivirine, Date of authorisation: 28/11/2011, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Edurant, rilpivirine, Date of authorisation: 28/11/2011, Revision: 22, Status: Authorised